Coronavirus evacuees monitored at Texas Center for Infectious Disease

Facility’s primary function is to treat tuberculosis patients


The Texas Center for Infectious Disease (TCID) in San Antonio is housing at least five people who tested positive for the coronavirus after being brought to Joint Base San Antonio-Lackland, according to an article on the KSAT website.

More than 18 people have been transferred off base, either to TCID or local hospitals, after showing symptoms of the virus or while awaiting test results.

Local leaders urge Department of Defense to keep coronavirus evacuees away from local healthcare facilities

It's unclear exactly how many of those 18 people are now at TCID.

The primary purpose of TCID is to treat tuberculosis patients.

Read the article.



March 12, 2020


Topic Area: Infection Control


Recent Posts

From Vacant to Vital: Adaptive Reuse of Retail Spaces

Adaptive reuse of big-box retail spaces is an increasingly popular way to expand access to healthcare in urban and suburban settings.


Community Health Network Falls Victim to Data Breach

The Indiana-based network has no evidence that any personal information has been or will be misused as a direct result of this incident.


Hudson Regional Health Launches 4-Hospital System

The launch comes after CarePoint’s bankruptcy plan was confirmed and went “effective.”


Must Know Recalls of 2025

For the safety of our readers, Healthcare Facilities Today has closely followed all recall notices related to the industry.


Sustainability as a Baseline in Healthcare Facilities

Hospitals can balance costs, build resilience and learn from global models for sustainable design to further their green goals.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.